Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct;42(10):2917-2918.
doi: 10.1007/s10067-023-06705-6. Epub 2023 Jul 28.

Multiple eruptive dermatofibromas associated with altered immunity and systemic lupus erythematosus

Po-Chien Wu  1   2   3 , Yi-Teng Hung  1   2 , Wei-Ti Chen  4   5   6   7
Affiliations
Editorial

Multiple eruptive dermatofibromas associated with altered immunity and systemic lupus erythematosus

Po-Chien Wu et al. Clin Rheumatol. 2023 Oct.
No abstract available

Keywords: Immunosuppressants; Multiple eruptive dermatofibromas; Systemic lupus erythematosus.

PubMed Disclaimer

References

    1. Huang PY, Chu CY, Hsiao CH (2007) Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate. J Am Acad Dermatol 57:S81–S84 - DOI - PubMed
    1. Seifi G, Kalantari Y, Etesami I (2022) Multiple dermatofibromas, associated clinical and histological characteristics: a systematic review. J Dtsch Dermatol Ges 20:1569–1579 - PubMed
    1. Niiyama S, Katsuoka K, Happle R, Hoffmann R (2002) Multiple eruptive dermatofibromas: a review of the literature. Acta Derm Venereol 82:241–244 - DOI - PubMed
    1. Collins L, Quinn A, Stasko T (2019) Skin cancer and immunosuppression. Dermatol Clin 37:83–94 - DOI - PubMed
    1. Gunawardane ND, Dontsi M, Lyon LL (2020) Risk of non-melanoma skin cancer in connective tissue disease and the impact of immunosuppressive therapy. J Drugs Dermatol 19:519–523 - DOI - PubMed

Publication types

MeSH terms